NCT04153604View on ClinicalTrials.gov

Doxycycline for the Prevention of Spontaneous Bacterial Peritonitis

CompletedOBSERVATIONAL
Enrollment

841

Participants

Timeline

Start Date

November 4, 2019

Primary Completion Date

August 7, 2020

Study Completion Date

August 7, 2020

Conditions
CirrhosisSpontaneous Bacterial Peritonitis
Interventions
DRUG

doxycycline

a tetracycline antibiotic that fights bacteria in the body.

Trial Locations (1)

75203

Methodist Dallas Medical Center, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER

NCT04153604 - Doxycycline for the Prevention of Spontaneous Bacterial Peritonitis | Biotech Hunter | Biotech Hunter